China began production of a possible cure for coronavirus

A drug that can potentially become effective in treatment of the novel coronavirus, was first produced in the Chinese province of Zhejiang. It is reported RIA Novosti with reference to the government of Taizhou.

As stated in the original message “of February 15 the drug “Pavalova”
(former name or Papilova Favipiravir), developed by the pharmaceutical
company of Zhejiang Hisun Pharmaceutical, officially approved by the State
the Department of supervision of food and drugs for
to market. This is the first drug that […] has received an official approval
for inclusion in the list of drugs which potentially can be effective in
the treatment of the novel coronavirus”.

It is noted that the drug can play a significant role in
treatment and prevention of the disease.

Director of the China national center for biotechnology development under the Ministry of science and technology of China Zhang Xinmin noted some types of medication, including Remdesivir (ramdevpir) and Japanese Favipiravir (Favipiravir), which showed clinical efficacy in the treatment of the novel coronavirus.

Previously, the Chinese doctors discovered that the transfusion of plasma of those patients who recovered from the new coronavirus COVID-19, allows to cure the sick.